Related Experiment Videos
Assessment of myocardial infarct size in clinical practice
Insights
Assessing myocardial infarct size using serum creatine phosphokinase (CPK) and QRS complex mapping helps predict heart failure. Larger infarcts correlate with severe heart failure symptoms.
Area of Science:
- Cardiology
- Biochemistry
Background:
- Myocardial infarction (MI) size is a critical determinant of patient prognosis.
- Accurate infarct size quantification is essential for effective patient management and risk stratification.
Purpose of the Study:
- To evaluate the utility of serial serum creatine phosphokinase (CPK) measurements and precordial QRS mapping for assessing myocardial infarct size.
- To correlate infarct size with clinical heart failure severity and prognostic outcomes.
Main Methods:
- Serial serum CPK levels were analyzed in 70 patients with first transmural MI.
- Precordial mapping of the QRS complex was performed in patients with anterior wall MI.
- Clinical assessment included heart failure classification (Killip stages) and radiological examination.
Main Results:
- Infarct size, assessed by CPK, correlated significantly with heart failure severity (Killip II-III vs. Killip I).
- Patients with lung edema had larger infarcts (average 104.2 CPK-g-equ) compared to those without heart failure (average 31.7 CPK-g-equ).
- A strong correlation (r = 0.916) was found between QRS complex Q wave voltages and enzymatically assessed infarct size in anterior wall MI.
Conclusions:
- Serial CPK analysis and precordial QRS mapping provide reliable methods for quantifying myocardial infarct size.
- Infarct size is a significant predictor of heart failure development and severity post-MI.
- These methods aid in the prognostic classification of patients following myocardial infarction.
Abstract:
The myocardial infarct size was assessed on the basis of serial analyses of serum creatine phosphokinase (CPK) in 70 patients with first transmural myocardial infarction. Clinical symptoms of heart failure (Killip II-III) were found in patients with infarcts larger than 50 CPK-g-equ; in patients with lung oedema the infarct size averaged 104.2 CPK-g-equ. Patients without clinical and roentgenological evidence of left heart failure (Killip I) had infarct sizes always lesser than 50 CPK-g-equ, averaging 31.7 CPK-g-equ. Precordial mapping of the QRS complex in patients with anterior wall infarction revealed a significant correlation (r = 0.916) between the sum of voltages of Q waves on a 30-lead map recorded 24 hours after hospitalization and the enzymically assessed infarct size. Exact skiagraphic and auscultatory examinations of the heart and lungs, together with precordial mapping of the QRS complex, in patients with anterior wall infarct allow a relatively accurate quantification of the infarct size for prognostic classification of the patients.